Medtronic was the only manufacturer of a leadless pacemaker in the U.S. market in the years after it won approval for its Micra device in 2016. While leadless pacemakers were designed to prevent lead- ...

Seven years after bringing the world's first leadless pacemaker (shown above) to the U.S. market, Medtronic has once again set a new pace in the industry with its next-generation leadless pacemakers.

A real-world study of Medtronic’s leadless pacemaker showed it led to fewer complications—with fewer patients having to return to the operating room—compared to wired cardiac implants over a period of ...

Medtronic has secured the FDA’s approval for the latest generation of its miniaturized, wireless pacemaker implants, the Micra AV2 and VR2. According to the company, the newest models can offer up to ...

DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ VR2, ...

Robert Kowal, MD, remembers vividly the day he was first introduced to the concept of Medtronic’s leadless pacemaker, which went on to become known as Micra. He was a practicing electrophysiologist ...

DALLAS (Reuters) - A new generation of Medtronic Inc's EnRhythm pacemaker programmed to kick in only when heart rhythm disturbances are detected led to fewer deaths, hospitalizations and incidences of ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

MUMBAI, IN / ACCESS Newswire / February 16, 2026 / Medtronic, a global leader in healthcare technology, has today launched the #DecodeYourRhythm campaign in India, a nationwide initiative to raise ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. In 1958 Earl Bakken an electrical ...

COLLEGE PARK, Md., March 19 (Reuters) - Medtronic Inc's experimental MRI-safe pacemaker should be approved despite limited clinical data as long as further study is done, U.S. health advisers ...